|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000092121 |
| 005 |
20200311093000.0 |
| 008 |
170808s2016 enk eng |
| 020 |
|
|
|a 1782620303
|
| 020 |
|
|
|a 1782622241
|
| 020 |
|
|
|a 9781782620303
|
| 020 |
|
|
|a 9781782622246
|
| 040 |
|
|
|a UniSZA
|e rda
|
| 050 |
0 |
0 |
|a RS403
|b .P75 2016
|
| 060 |
1 |
0 |
|a QV 744
|b .P945 2016
|
| 090 |
0 |
0 |
|a RS403
|b .P75 2016
|
| 245 |
1 |
0 |
|a Privileged scaffolds in medicinal chemistry :
|b design, synthesis, evaluation
|c edited by Stefan Brase
|
| 264 |
|
1 |
|a Cambridge :
|b Royal Society of Chemistry
|c c2016
|
| 300 |
|
|
|a xviii, 468 pages :
|b illustrations ;
|c 24 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 490 |
1 |
|
|a RSC drug discovery
|v 50
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a 1. Privileged Scaffolds in Medicinal Chemistry: An Introduction -- 2. Privileged Scaffolds in Medicinal Chemistry -- 3. The B-lactam (azetidine-2-one) as a privileged ring in medicinal chemistry -- 4. (Benz) imidazoles -- 5. Pyrazoles -- 6. Quinolines: privileged scaffolds in medicinal chemistry -- 7. Isoquinolines -- 8. Rhodanine -- 9. Heterocycles containing nitrogen and sulfur as potent biologically active scaffolds -- 10. Coumarins -- 12. Xanthones are privileges scaffolds in medicinal chemistry-but are they over-privileged -- 13. Natural product scaffolds of value in medicinal chemistry -- 14. Ergot alkaloids -- 15. Cyclic peptides as privileged structures -- 16. Spirocycles as privileged structural motifs in medicinal chemistry
|
| 650 |
|
0 |
|a Drug development
|
| 650 |
|
0 |
|a Molecular pharmacology
|
| 650 |
|
0 |
|a Pharmaceutical chemistry
|
| 650 |
|
2 |
|a Chemistry, Pharmaceutical
|
| 650 |
2 |
2 |
|a Drug Discovery
|
| 650 |
2 |
2 |
|a Heterocyclic Compound
|x chemistry
|
| 700 |
1 |
|
|a Brase, Stefan ,
|e editor
|
| 999 |
|
|
|a 1000169171
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|